Page 120 - CIBEREHD2016-ENG

LEAD rESEArCHEr
Sangro Gómez-Acebo, Bruno Carlos
Clínica Universidad de Navarra
C/ Pio XII, 36 31008 Pamplona
(+34) 948 25 54 00 ext 4764 [email protected] group Website
GROUP MEMBERS
Staff members: Álvarez Sola, Gloria | Barbero López, Roberto | D’avola, Delia | Santa María Monasterio, Eva | Uriarte Díaz Varela, Iker
Associated members: Ávila Zaragoza, Matías Antonio | Berasain Lasarte, Carmen | Civeira Murillo, María Pilar | Concepción González, Axel Rolando | Corrales Izquierdo, Fernando José | Fontanellas Romas, Antonio | García Fernández De Barrena, Maite | García González, Javier Nicolás | Herrero Santos, José Ignacio | Iñarrairaegui Bastarrica, Mercedes | López Martínez, María | Quiroga Vila, Jorge | Rodríguez Ortigosa, Carlos Manuel | Sáez de Blas, Elena | Sarvide Plano, Sarai
Main lines of research
• Study of the cellular and molecular mechanisms of liver response to acute and chronic injury, and hepatocarcinogenesis .
• Design of hepatoprotective strategies against situations of injury/acute liver failure and identification of therapeutic targets to slow the progression of chronic liver disease and its malignant transformation.
• Development of hepatoprotective therapies including insulin-like growth factor type 1 (IGF1) and cell
therapy with endothelial cell progenitors.
• Characterization of the effects of amino-terminal protein modifications and their implications for the
development of hepatocellular carcinoma and liver regeneration, and development of inhibitors of
these enzymes as novel antitumor molecules.
• Clinical development of new agents with specific therapeutic targets.
120
PROGRAMMES
P4